|
Market Closed -
Saudi Arabian S.E.
12:35:29 06/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 64.80 SAR | +2.45% |
|
+5.88% | +1.98% |
| 06/11 | SNB Capital Cuts Avalon Pharma's PT, Confirms Neutral Rating | MT |
| 04/11 | Avalon Pharma's Q3 Attributable Net Profit, Revenue Rise | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.45% | +5.88% | +2.05% | +10.20% | +1.98% | -10.71% | - | - | - | 604M | |
| +0.14% | -4.04% | +17.52% | +14.12% | +26.57% | +45.10% | +128.54% | +422.10% | +1,741.13% | 1,216B | |
| +1.00% | +0.58% | +7.85% | +6.92% | +32.77% | +46.96% | +81.13% | +68.71% | +135.53% | 656B | |
| +0.86% | -1.54% | +8.87% | +19.06% | +27.07% | +32.56% | +105.63% | +150.17% | +392.87% | 509B | |
| -0.36% | -3.25% | +11.58% | +7.02% | +18.92% | +47.17% | +64.58% | +6.65% | +73.78% | 384B | |
| -0.22% | -1.99% | +3.25% | +14.16% | +39.23% | +70.84% | +40.45% | +77.25% | +144.05% | 362B | |
| -0.78% | -0.52% | +13.57% | +6.31% | +21.42% | +30.57% | +57.98% | +74.97% | +92.03% | 311B | |
| -0.80% | -0.21% | +16.49% | +17.55% | +1.02% | +8.54% | +35.56% | +49.29% | +214.41% | 293B | |
| -0.05% | -1.05% | +14.54% | +13.90% | +40.88% | +46.12% | +69.02% | +118.16% | +231.25% | 249B | |
| -0.47% | -1.86% | +16.14% | +28.01% | +36.48% | +35.75% | +106.45% | +153.92% | +126.36% | 208B | |
| -0.66% | +1.26% | +9.73% | -8.23% | -17.16% | -12.22% | -61.57% | -26.94% | +134.20% | 180B | |
| -0.49% | -4.18% | +6.35% | +11.62% | +17.45% | +17.69% | -6.21% | -39.49% | -3.74% | 170B | |
| +0.96% | -2.05% | +8.99% | +13.10% | +20.75% | +31.52% | +41.91% | +184.79% | +557.83% | 138B | |
| -1.62% | -0.58% | +4.25% | -3.16% | +15.16% | +33.22% | +17.67% | +4.56% | +18.05% | 129B | |
| -0.91% | +6.89% | +15.34% | +22.00% | +29.60% | +23.82% | +131.10% | +382.72% | +690.35% | 124B | |
| -0.93% | +5.02% | +18.60% | +12.69% | +1.23% | -2.18% | -1.41% | -5.07% | +15.87% | 114B | |
| +5.43% | +18.60% | +40.28% | +388.23% | +791.69% | +980.81% | +264.87% | +7.47% | - | 96.4B | |
| 0.00% | +1.89% | +7.05% | -2.40% | +3.59% | +6.27% | +34.52% | -2.96% | -2.39% | 102B | |
| +0.13% | -2.19% | +22.86% | +17.55% | +17.58% | +40.31% | +9.03% | +45.73% | +148.39% | 90.6B | |
| -1.06% | -1.69% | +7.01% | +2.48% | +21.33% | +34.86% | +1.47% | -28.55% | +61.16% | 73.36B | |
| Average | +0.04% | +3.32% | +12.61% | +29.56% | +57.38% | +75.35% | +58.99% | +86.50% | +265.06% | 270.24B | |
| Weighted average by Cap. | -0.01% | +1.24% | +12.66% | +18.62% | +37.40% | +53.73% | +76.32% | +153.23% | +540.52% |
- Stock Market
- Stocks
- 4016 Stock
- Sector Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
